Wired via HotAir
Neither company was a household name before the pandemic. In fact, neither had ever had a single drug approved before. But both had long believed that their mRNA technology, which uses simple genetic instructions as a payload, could outpace traditional vaccines, which rely on the often-painstaking assembly of living viruses or their isolated parts. mRNA turned out to be a vanishingly rare thing in the world of science and medicine: a promising and potentially transformative technology that not only survived its first big test, but delivered beyond most people’s wildest expectations. But its next step could be even bigger. The scope of mRNA vaccines always went beyond any one disease. Like moving from a vacuum tube to a microchip, the technology promises to perform the same task as traditional vaccines, but exponentially faster, and for a fraction of the cost. "You can have an idea in the morning, and a vaccine prototype by evening. The speed is amazing," says Daniel Anderson, an mRNA therapy researcher at MIT. Before the pandemic, charities including the Bill & Melinda Gates Foundation and the Coalition for Epidemic Preparedness Innovations (CEPI) hoped to turn mRNA on deadly diseases that the pharmaceutical industry has largely ignored, such as dengue or Lassa fever, while industry saw a chance to speed up the quest for long-held scientific dreams: an improved flu shot, or the first effective HIV vaccine. Amesh Adalja, an expert on emerging diseases at the Johns Hopkins Center for Health Security, in Maryland, says mRNA could "make all these applications we were hoping for, pushing for, become part of everyday life." "When they write the history of vaccines, this will probably be a turning point," he adds.
Personally, I also enjoy people (term used solely for purposes of reference) who can't be bothered to read the relevant wiki article: https://en.wikipedia.org/wiki/Promoter_(genetics) - screaming their heads off about "genetic engineering". 
|
But both had long believed that their mRNA technology, which uses simple genetic instructions as a payload.........